SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is seeing increased market volatility and investor scrutiny as the community closely monitors the upcoming BlueBird satellite launch and broader sector developments, including rumored SpaceX IPO activity and shifting geopolitical tensions. While bears cite concerns over historical delays and intense short interest, bulls are aggressively defending the stock, highlighting the companys strategic cellular broadband technology and recent partnerships as catalysts for a potential rebound.

Maul Coin

Maul Coin is trending as the community actively rallies behind the project's development milestones, including website and whitepaper launches, while pushing to secure a official chart listing. Despite some skepticism and volatility, supporters remain focused on long-term growth, citing transparent leadership and strong grassroots momentum as key drivers for potential future gains.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvell Technology is drawing significant investor attention following a major strategic partnership and a $2 billion investment from Nvidia aimed at expanding their collaborative footprint in AI infrastructure, specifically through NVLink Fusion and silicon photonics. The community is heavily focused on this 'titan-synergy,' with bullish sentiment driven by Marvell's role in the AI interconnect supercycle and Bank of America's recent price target hike, even as some traders caution against volatility and Gamma-related price swings surrounding key resistance levels.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines is surging as investors react to the successful Artemis II launch and rumors surrounding a potential SpaceX IPO, which have reignited broad interest in the space sector. Community members are actively debating the company's long-term revenue potential and strategic role in lunar infrastructure while expressing strong enthusiasm for its recent momentum and upcoming mission milestones.

Avalanche is a high throughput smart contract blockchain&nbsp;platform. Validators secure the network through a proof-of-stake consensus protocol. It is said to be fast, low cost, and environmental friendly.

Avalanche

Avalanche is currently trending as investors weigh its potential for institutional adoption against persistent market volatility and legislative uncertainty. The community remains divided, with some actively accumulating at current levels due to the project's utility and ETF developments, while others express frustration over extended price declines and broader market headwinds.

Oric Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development of cancer treatments that address mechanisms of therapeutic resistance. It specializes in hormone-dependent cancers, key tumor dependencies, and precision oncology. The company was founded by Charles L. Sawyers, Richard A. Heyman, and Scott Lowe in 2014 and is headquartered in South San Francisco, CA.

ORIC Pharmaceuticals Inc

ORIC Pharmaceuticals is seeing intense volatility and high trading volume as investors react to a new clinical development collaboration with Pfizer, which also included a strategic equity investment at a significant premium. The community is heavily focused on the potential for a short squeeze given the high interest, though sentiment remains divided between those betting on long-term institutional backing and those cautious of the recent rapid price fluctuations.

FuelCell Energy, Inc. engages in the business of developing, designing, producing, constructing, and servicing high temperature fuel cells for clean electric power generation. It operates through the following geographical segments: the United States, South Korea, and Europe. The company was founded by Bernard Baker and Martin G. Klein in 1969 and is headquartered in Danbury, CT.

Fuelcell Energy Inc

FuelCell Energy is currently capturing community attention as investors weigh the stock's high-risk, high-reward potential against its ongoing execution challenges and lack of recent large-scale contract announcements. While bulls highlight the companys strategic positioning to capitalize on surging AI-driven data center power demand, skeptics remain vocal about historical share dilution and the stock's persistent underperformance relative to industry peers like Bloom Energy.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

SOXL is seeing heightened volatility as retail traders remain divided over the impact of ongoing geopolitical tensions in the Strait of Hormuz and the potential for a broader market correction. The community is actively debating whether recent price swings represent a sustainable rebound or a classic bull trap, with many closely tracking updates from the White House regarding the conflict's resolution to determine their next entry point.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion is capturing significant community attention following Google's recent pivot to neutral-atom quantum computing, a move investors view as strong validation of the company's core technology and potential for future M&A. While some market participants express frustration over recent price volatility and general market headwinds, others are actively accumulating shares, viewing the current valuation as a long-term entry point for a sector they believe is poised to mirror the growth trajectory of AI.

Velo3D, Inc. operates as a technology company, which engages in developing and manufacturing metal laser sintering printing machines for 3D printing. Its products include assure system, flow software, sapphire printer & sapphire XC. The company was founded by Benyamin Buller in June 2014 and is headquartered in Fremont, CA.

Velo3D Inc

Velo3D is currently drawing significant attention as investors react to key debt-to-equity conversions that bolstered the company's balance sheet, fueling optimism about its ability to scale production for major defense and aerospace contracts. Community discussions are heavily centered on the company's critical role in supply chains for entities like SpaceX and Anduril, with many traders anticipating that forthcoming production milestones will catalyze a sustained upward move.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Given Consensus Rating of "Moderate Buy" by Brokerages

Shares of Karyopharm Therapeutics Inc. (NASDAQ:KPTI - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the eight research firms that are presently covering the stock...

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Short Interest Up 20.9% in March

Karyopharm Therapeutics Inc. (NASDAQ:KPTI - Get Free Report) was the recipient of a significant growth in short interest during the month of March. As of March 13th, there was short interest totaling...

Piper Sandler Reaffirms "Overweight" Rating for Karyopharm Therapeutics (NASDAQ:KPTI)

Piper Sandler reiterated an "overweight" rating and set a $8.00 target price (down from $12.00) on shares of Karyopharm Therapeutics in a research note on Monday...

Karyopharm Therapeutics (KPTI) Stock Jumps 6.9%: Will It Continue to Soar?

Karyopharm Therapeutics (KPTI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

HC Wainwright Has Optimistic Outlook of KPTI Q1 Earnings

Karyopharm Therapeutics Inc. (NASDAQ:KPTI - Free Report) - Analysts at HC Wainwright boosted their Q1 2026 EPS estimates for Karyopharm Therapeutics in a note issued to investors on Wednesday, March...

KPTI Stock Down on Mixed Phase III Myelofibrosis Combo Study Data

Karyopharm Therapeutics stock sinks 18% after mixed phase III data show spleen benefit but no symptom edge for selinexor combo in myelofibrosis, raising questions on efficacy.

Karyopharm Therapeutics (NASDAQ:KPTI) Price Target Lowered to $15.00 at Robert W. Baird

Robert W. Baird reduced their price target on Karyopharm Therapeutics from $21.00 to $15.00 and set an "outperform" rating for the company in a report on Wednesday...

Assertio (ASRT) Surges 17.9%: Is This an Indication of Further Gains?

Assertio (ASRT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.

HC Wainwright Lowers Karyopharm Therapeutics (NASDAQ:KPTI) Price Target to $8.00

HC Wainwright decreased their price objective on Karyopharm Therapeutics from $15.00 to $8.00 and set a "buy" rating for the company in a research note on Wednesday...

Nuclear Stocks Worth Watching - March 24th

Oklo, NuScale Power, Karyopharm Therapeutics, BWX Technologies, and Centrus Energy are the five Nuclear stocks to watch today, according to MarketBeat's stock screener tool. "Nuclear stocks" are...

Karyopharm Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company was founded by Joseph Araujo, Ronald A. DePinho, Pamela A, Silver, Giulio Draetta, Michael G. Kauffman, and Sharon Shacham on December 22, 2008, and is headquartered in Newton, MA.

Karyopharm Therapeutics Inc

Opendoor ($OPEN)

Strategy ($MSTR)

American Eagle ($AEO)

Ondas Inc. ($ONDS)

The stock that proved the power of the crowd. Fueled by community energy and social momentum, this winner captivated retail investors regardless of what the "experts" or traditional fundamentals had to say.

KPTI
Karyopharm Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest KPTI News

KPTIKaryopharm Therapeutics Inc